[Pharmacology of glucocorticoids and ENT pathology].

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Presse medicale

• Publication date

  2001-12-22

• Fields of study

  Medicine

• Identifiers
  PMID 11819915
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nasal bioavailability and systemic effects of the glucocorticoid budesonide in man

  2004cited by this paper
• Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray.

  2000cited by this paper
• Inhaled and nasal corticosteroids: safety aspects*

  2000cited by this paper
• Clinical and pathologic methods to assess the long-term safety of nasal corticosteroids. French Triamcinolone Acetonide Study Group.

  2000cited by this paper
• Suppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment.

  2000cited by this paper
• Risk of cataract among users of intranasal corticosteroids.

  2000cited by this paper
• Molecular mechanisms of glucocorticosteroid actions.

  2000cited by this paper
• [Evaluation of the hypothalamo-hypopituitary axis after long-term inhalation corticotherapy for nasal polyposis].

  2000cited by this paper
• Systemic corticosteroid treatment for seasonal allergic rhinitis:a common but poorly documented therapy

  2000cited by this paper
• The Effect of Corticosteroids in the Treatment of Experimental Sinusitis

  2000cited by this paper
• Transcriptional potencies of inhaled glucocorticoids.

  2000cited by this paper
• Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate.

  2000cited by this paper
• Safety of Inhaled and Intranasal Corticosteroids

  2000cited by this paper
• Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways.

  1999cited by this paper
• Effect of intranasal fluticasone on cellular infiltration, endothelial adhesion molecule expression, and proinflammatory cytokine mRNA in nasal polyp disease.

  1999cited by this paper
• 24 hour and fractionated profiles of adrenocortical activity in asthmatic patients receiving inhaled and intranasal corticosteroids

  1999cited by this paper
• The effect of six weeks topical nasal betamethasone drops on the hypothalamo-pituitary-adrenal axis and bone turnover in patients with nasal polyposis.

  1999cited by this paper
• Effect of Steroids on Nasal Inflammatory Cells and Cytokine Profile

  1999cited by this paper
• Effect of topical fluticasone propionate on the mucosal allergic response induced by ragweed allergen and diesel exhaust particle challenge.

  1999cited by this paper
• Long‐term effects of corticosteroid nasal spray on nasal inflammatory cells in patients with perennial allergic rhinitis

  1999cited by this paper
• An in vitro comparison of commonly used topical glucocorticoid preparations.

  1999cited by this paper
• Inhaled and nasal corticosteroids: factors affecting the risks of systemic adverse effects.

  1999cited by this paper
• Inhibition of cPLA2 translocation and leukotriene C4 secretion by fluticasone propionate in exogenously activated human eosinophils.

  1999cited by this paper
• Effect of fluticasone propionate aqueous nasal spray on allergen‐induced inflammatory changes in the nasal airways of allergic rhinitics following exposure to nitrogen dioxide

  1999cited by this paper
• Short-term lower leg growth rate in children with rhinitis treated with intranasal mometasone furoate and budesonide.

  1999cited by this paper
• [Mechanism of action of glucocorticoids in asthma].

  1999cited by this paper
• Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part II: clinical studies with leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma.

  1999cited by this paper
• Intranasal corticosteroids for allergic rhinitis: how do different agents compare?

  1999cited by this paper
• Glucocorticoid suppresses autocrine survival of mast cells by inhibiting IL-4 production and ICAM-1 expression.

  1999cited by this paper
• Effect of intranasal corticosteroids on release of cytokines and inflammatory mediators

  1999cited by this paper
• A 1-year placebo-controlled study of intranasal fluticasone propionate aqueous nasal spray in patients with perennial allergic rhinitis: a safety and biopsy study.

  1998cited by this paper
• Effect of mometasone furoate on early and late phase inflammation in patients with seasonal allergic rhinitis.

  1998cited by this paper
• Influence of inhaled corticosteroids on growth: a pediatric endocrinologist's perspective

  1998cited by this paper
• Interleukin-4, interleukin-5, and granulocyte-macrophage colony-stimulating factor receptor expression in chronic sinusitis and response to topical steroids

  1998cited by this paper
• Inhaled corticosteroids and growth in children.

  1998cited by this paper
• Effects of repeated once daily dosing of three intranasal corticosteroids on basal and dynamic measures of hypothalamic-pituitary-adrenal-axis activity.

  1998cited by this paper
• Assessment by Nasal Biopsy of Long-Term Use of Mometasone Furoate Aqueous Nasal Spray (Nasonex) in the Treatment of Perennial Rhinitis

  1998cited by this paper
• Effects of intranasal corticosteroids on adrenal, bone, and blood markers of systemic activity in allergic rhinitis.

  1998cited by this paper
• Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology.

  1998cited by this paper
• Nasal eosinophilia and IL-5 mRNA expression in seasonal allergic rhinitis induced by natural allergen exposure: effect of topical corticosteroids.

  1998cited by this paper
• Differential regulation of cyclo‐oxygenase‐2 and 5‐lipoxygenase‐activating protein (FLAP) expression by glucocorticoids in monocytic cells

  1997cited by this paper
• Allergic rhinitis and inflammation: the effect of nasal corticosteroid therapy

  1997cited by this paper
• In vivo induction and regulation of interleukin-8-like chemokine GRO/CINC-1 in rat middle ear.

  1997cited by this paper
• Glucocorticoids decrease tissue mast cell number by reducing the production of the c-kit ligand, stem cell factor, by resident cells: in vitro and in vivo evidence in murine systems.

  1997cited by this paper
• IL-13 mRNA and immunoreactivity in allergen-induced rhinitis: comparison with IL-4 expression and modulation by topical glucocorticoid therapy.

  1997cited by this paper
• Effect of topical anti-inflammatory drugs on epithelial cell-induced eosinophil survival and GM-CSF secretion.

  1997cited by this paper
• Safety and tolerability of once-daily mometasone furoate aqueous nasal spray in children.

  1997cited by this paper
• Protection by dexamethasone of the functional desensitization to β2‐adrenoceptor‐mediated responses in human lung mast cells

  1997cited by this paper
• Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases.

  1997cited by this paper
• The inhibitory effects of topically active glucocorticoids on IL-4, IL-5, and interferon-gamma production by cultured primary CD4+ T cells.

  1997cited by this paper
• IL-4 and IL-13 expression in chronic sinusitis: relationship with cellular infiltrate and effect of topical corticosteroid treatment.

  1997cited by this paper
• The effect of fluticasone propionate aqueous nasal spray on eosinophils and cytokines in nasal secretions of patients with ragweed allergic rhinitis.

  1997cited by this paper
• Ligand-induced differentiation of glucocorticoid receptor (GR) trans-repression and transactivation: preferential targetting of NF-kappaB and lack of I-kappaB involvement.

  1996cited by this paper
• Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor.

  1996cited by this paper
• Glucocorticosteroid inhibition of cytokine production: relevance to antiallergic actions.

  1996cited by this paper
• In vivo effect of prednisolone on release of leukotriene B4 from neutrophils from asthmatic patients.

  1996cited by this paper
• Regulation of histamine H1 receptor coupling by dexamethasone in human cultured airway smooth muscle

  1996cited by this paper
• Antigen presenting cells in the nasal mucosa of patients with allergic rhinitis during allergen provocation

  1996cited by this paper
• Intranasal fluticasone propionate inhibits recovery of chemokines and other cytokines in nasal secretions in allergen-induced rhinitis.

  1996cited by this paper
• Secretion of chemokines and other cytokines in allergen-induced nasal responses: inhibition by topical steroid treatment.

  1995cited by this paper
• Effects of intranasal glucocorticoids on endogenous glucocorticoid peripheral and central function.

  1995cited by this paper
• Effect of 3 months’ nasal steroid therapy on nasal T cells and Langerhans cells in patients suffering from allergic rhinitis

  1995cited by this paper
• Interleukin-5 and eosinophil cationic protein in nasal lavages of rhinitis patients.

  1995cited by this paper
• Cytokine immunoreactivity in seasonal rhinitis: regulation by a topical corticosteroid.

  1995cited by this paper
• Enhanced arachidonic acid metabolism in alveolar macrophages from wheezy infants. Modulation by dexamethasone.

  1995cited by this paper
• Effect of oral prednisone on airway inflammatory mediators in atopic asthma.

  1994cited by this paper
• Nasal cytology in patients with allergic rhinitis: effects of intranasal fluticasone propionate.

  1994cited by this paper
• Lipocortin-1: cellular mechanisms and clinical relevance.

  1994cited by this paper
• Molecular mechanisms of action of steroid/thyroid receptor superfamily members.

  1994cited by this paper
• Topical glucocorticosteroid (fluticasone propionate) inhibits cells expressing cytokine mRNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis.

  1994cited by this paper
• Effect of short-term treatment with fluticasone propionate nasal spray on the response to nasal allergen challenge.

  1994cited by this paper
• Influence of prolonged treatment with topical corticosteroid (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasal mucosa after allergen challenge

  1994cited by this paper
• The effects of glucocorticoids on human eosinophils.

  1994cited by this paper
• Differential effects of fluticasone propionate on allergen-evoked bronchoconstriction and increased urinary leukotriene E4 excretion.

  1993cited by this paper
• Macrophage-specific eicosanoid synthesis inhibition and lipocortin-1 induction by glucocorticoids.

  1993cited by this paper
• Characterization of vasocortin-like proteins induced by dexamethasone in endothelial cells.

  1993cited by this paper
• Phospholipase A2 enzymes: regulation and inhibition.

  1993cited by this paper
• Dose tolerance study of fluticasone propionate aqueous nasal spray in patients with seasonal allergic rhinitis.

  1991cited by this paper
• Inhibition of eicosanoid biosynthesis by glucocorticoids in humans.

  1990cited by this paper
• The human pharmacology of fluticasone propionate.

  1990cited by this paper
• An assessment of the effects of glucocorticoids on degranulation, chemotaxis, binding to vascular endothelium and formation of leukotriene B4 by purified human neutrophils.

  1989cited by this paper
• Prostaglandins, leukotrienes, and other arachidonic acid metabolites in the pathogenesis of otitis media

  1988cited by this paper
• Arachidonic acid metabolism in cultured alveolar macrophages from normal, atopic, and asthmatic subjects.

  1988cited by this paper
• Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticosteroids.

  1987cited by this paper
• Selective inhibition of arachidonic acid metabolite release from human lung tissue by antiinflammatory steroids.

  1986cited by this paper
• Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells.

  1983cited by this paper

• Randomised trial on performance, safety and clinical benefit of hyaluronic acid, hyaluronic acid plus dexpanthenol and isotonic saline nasal sprays in patients suffering from dry nose symptoms.

  2020cites this paper
• Impact of Vitamin D on Mast Cell Activity, Immunity and Inflammation

  2016cites this paper
• Non-genomic action of beclomethasone dipropionate on bronchoconstriction caused by leukotriene C4 in precision cut lung slices in the horse

  2012cites this paper
• Что мы знаем о безопасности интраназальных кортикостероидов

  2012cites this paper
• Ostre infekcje górnych dróg oddechowych u dzieci - podział morfologiczny, diagnostyka i terapia

  2010cites this paper
• Pharmacological Agents in Implant Dentistry

  2010cites this paper
• Efeitos relacionados ao uso do esteróide inalado na saúde periodontal que o médico precisa conhecer

  2007cites this paper
• Glucocorticosteroids in football: use and misuse

  2006cites this paper
• Glucocorticosteroids in allergic inflammation: clinical benefits in allergic rhinitis, rhinosinusitis, and otitis media.

  2005cites this paper
• Uteroglobin Represses Allergen-induced Inflammatory Response by Blocking PGD2 Receptor–mediated Functions

  2004cites this paper
• Poliposis nasosinusal del adulto

  2004cites this paper
• Polypose nasosinusienne chez l'adulte

  2003cites this paper